Nutritional impact of antipseudomonas intravenous antibiotic courses in cystic fibrosis
Open Access
- 1 May 1997
- journal article
- clinical trial
- Published by BMJ in Archives of Disease in Childhood
- Vol. 76 (5), 437-440
- https://doi.org/10.1136/adc.76.5.437
Abstract
OBJECTIVE To evaluate the short term effects on nutritional status of home intravenous anti-pseudomonas antibiotic courses in cystic fibrosis (CF) patients chronically colonised withPseudomonas aeruginosa. DESIGN A prospective study involving 38 CF patients, mean age 10.9 (SD 4.3) years (range 4.3 to 22.2 years), presenting with pulmonary exacerbations of P aeruginosainfection. The patients received a 14 day antibiotic course of intravenous ceftazidime (200 mg/kg/day) and either amikacin (35 mg/kg/day) or tobramycin (15 mg/kg/day). Nutritional evaluation on days 1 and 14 involved measurements of weight, weight/height ratio (per cent of predicted value), energy intake (per cent of recommended daily allowances), serum prealbumin, and body composition assessed by two methods: bioelectrical analysis (BIA) and skinfold anthropometry. The non-parametric Wilcoxon t test was used for statistical analysis, with a Bland-Altman plot to assess the degree of agreement between the two methods of evaluating body composition. RESULTS Weight increased by 1.0 (0.8) kg (p < 0.001); weight/height increased from 94.4(12.2)% to 98(12.7)% (p < 0.001), energy intake from 107(32)% to 119(41)% (p < 0.02), and prealbumin from 183 (63) to 276 (89) mg/l (p < 0.001). Fat mass increased by 0.8 (1.0) kg (p < 0.001), without any significant change in fat-free mass. The limits of agreement between BIA and anthropometry were –0.7 kg and +1.1 kg. CONCLUSIONS Antibiotic courses allow an improvement in nutritional status in CF patients, with a gain in fat mass.Keywords
This publication has 20 references indexed in Scilit:
- Are Bioelectric Impedance Measurements Valid in Patients with Cystic Fibrosis?Journal of Pediatric Gastroenterology and Nutrition, 1994
- Relation between Tumor Necrosis Factor-alpha and Granulocyte Elastase-α1-Proteinase Inhibitor Complexes in the Plasma of Patients with Cystic FibrosisAmerican Review of Respiratory Disease, 1989
- Nutritional Requirements in Cystic FibrosisJournal of Pediatric Gastroenterology and Nutrition, 1988
- The Impact of Nutrition in Cystic FibrosisJournal of Pediatric Gastroenterology and Nutrition, 1988
- Short-term nutritional supplementation during management of pulmonary exacerbations in cystic fibrosis: a controlled study, including effects of protein turnoverThe American Journal of Clinical Nutrition, 1988
- Energy expenditure of patients with cystic fibrosisThe Journal of Pediatrics, 1987
- FREQUENT ANTIBIOTIC THERAPY IMPROVES SURVIVAL OF CYSTIC FIBROSIS PATIENTS WITH CHRONIC PSEUDOMONAS AERUGINOSA INFECTIONActa Paediatrica, 1983
- RELATIVE UNDERWEIGHT IN CYSTIC FIBROSIS AND ITS PROGNOSTIC VALUEActa Paediatrica, 1978
- Determination of Body Composition of Children from Skinfold MeasurementsArchives of Disease in Childhood, 1971
- The assessment of the amount of fat in the human body from measurements of skinfold thicknessBritish Journal of Nutrition, 1967